| 1 |
Durand F. How to improve long-term outcome after liver transplantation? [J]. Liver Int, 2018, 38(Suppl 1): 134-138.
|
| 2 |
Leibovici-Weissman Y, Anchel N, Nesher E, et al. Early post-liver transplantation infections and their effect on long-term survival [J]. Transpl Infect Dis, 2021, 23(4): e13673.
|
| 3 |
Theodoropoulos N, Ison MG. Donor-derived infections: incidence, prevention, and management [J]. Transplant Infections, 2016, 15(2): 113-127.
|
| 4 |
Li H, Zhang J, Wang Z, et al. Evolution of Acinetobacter baumannii in clinical bacteremia patients [J]. Infect Drug Resist, 2021, 14: 3553-3562.
|
| 5 |
Green M, Covington S, Taranto S, et al. Donor-derived transmission events in 2013: a report of the Organ Procurement Transplant Network Ad Hoc Disease Transmission Advisory Committee [J]. Transplantation, 2015, 99(2): 282-287.
|
| 6 |
张建蕊, 孙丽莹, 朱志军, 等. 供者来源性感染对肝移植受者的影响 [J/CD]. 实用器官移植电子杂志, 2018, 1(6): 17-20.
|
| 7 |
Romero FA, Razonable RR. Infections in liver transplant recipients [J]. World J Hepatol, 2011, 3(4): 83-92.
|
| 8 |
Liu D, Zhang J, Wu B, et al. Impact of donor lung colonized bacteria detected by next-generation sequencing on early post-transplant outcomes in lung transplant recipients [J]. BMC Infect Dis, 2020, 20: 689.
|
| 9 |
Huang JF, Miao Q, Cheng JW, et al. Metagenomic next-generation sequencing versus traditional laboratory methods for the diagnosis and treatment of infection in liver transplantation [J]. Front Cell Infect Microbiol, 2022, 12: 886359.
|
| 10 |
Bartoletti M, Giannella M, Tedeschi S, et al. Multidrug-resistant bacterial infections in solid organ transplant candidates and recipients [J]. Infect Dis Clin North Am, 2018, 32(3): 551-580.
|
| 11 |
Soave R. Prophylaxis strategies for solid-organ transplantation [J]. Clin Infect Dis, 2001, 33(Suppl 1): S26-31.
|
| 12 |
Abad CLR, Lahr BD, Razonable RR. Epidemiology and risk factors for infection after living donor liver transplantation [J]. Liver Transpl, 2017, 23: 465-477.
|
| 13 |
Lanini S, Costa AN, Puro V, et al. Incidence of carbapenem-resistant gram negatives in Italian transplant recipients: a nationwide surveillance study [J]. PLoS One, 2015, 10(4): e0123706.
|
| 14 |
Eyraud D, Ben Ayed S, Tanguy ML, et al. Procalcitonin in liver transplantation: are high levels due to donors or recipients? [J]. Crit Care, 2008,12(4): R85.
|
| 15 |
Hu F, Zhu D, Wang F, et al. Current status and trends of antibacterial resistance in China [J]. Clin Infect Dis, 2018, 67(suppl 2): S128-S134.
|
| 16 |
Peleg AY, Potoski BA, Rea R, et al. Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report [J]. J Antimicrob Chemother, 2007, 59(1): 128-131.
|
| 17 |
Viehman JA, Nguyen MH, Doi Y. Treatment options for carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii infections [J]. Drugs, 2014, 74(12): 1315-1333.
|